BRÈVE

sur Zentek Ltd. (NASDAQ:ZTEK)

Zentek and Triera Biosciences Secure $1.1 Million Government Contract

Graphique de l'évolution du cours de l'action Zentek Ltd. (EBR:ZTEK).

Zentek Ltd.'s subsidiary, Triera Biosciences Ltd., has been awarded a $1.1 million contract by the Government of Canada. The funding supports the testing of Triera's multivalent aptamer technology aimed at rapid drug discovery for avian influenza A(H5N1). This initiative aligns with Canada's focus on advancing the life sciences sector through Innovation, Science and Economic Development Canada's program.

The multivalent aptamer platform has previously shown potential by developing solutions effective against all variants of SARS-CoV-2. With this contract, Triera aims to develop a lead candidate within six months, in collaboration with agencies like Health Emergency Readiness Canada and Defence Research and Development Canada.

The project's success could lead to further government support and development opportunities for Triera's avian flu program, highlighting the importance of proactive outbreak responses.

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Zentek Ltd.